Showing results (31-40 of 74) with videos related to

Sort By:
Pageof 8
Plos One|July 25, 2015
Suramin Inhibits Chikungunya Virus Entry and TransmissionYi-Jung Ho, Yu-Ming Wang, Jeng-wei Lu, et al.
In Vivo (Athens, Greece)|January 2, 2026
Rhupus Syndrome With Multiple Drug Intolerances Managed by Reduced-dose Rituximab and Adjunctive Molecular Hydrogen Therapy: A Case ReportHan-Luen Tsai, Jeng-Wei Lu, Yi-Jung Ho, et al.
In Vivo (Athens, Greece)|January 2, 2026
Longitudinal Immune Profiling of T Cell Exhaustion During IL-17A Blockade in a Patient With HLA-B27-negative Spondyloarthritis and Sjögren's Syndrome: A Case ReportYu-Siang Su, Jeng-Wei Lu, Yi-Jung Ho, et al.
In Vivo (Athens, Greece)|April 28, 2026
Adjunctive Molecular Hydrogen Capsule Therapy in Empyema Complicated by Chronic Inflammatory Demyelinating Polyneuropathy: A Case ReportGuan-Long Li, Jeng-Wei Lu, Yi-Jung Ho, et al.
SAGE Open Medical Case Reports|June 8, 2026
Molecular hydrogen is associated with immunophenotypic modulation and changes in T-cell exhaustion markers in refractory primary Sjögren's syndrome-associated interstitial lung disease: A case reportWei-Hung Hsu, Jeng-Wei Lu, Yi-Jung Ho, et al.
Journal of Cellular and Molecular Medicine|January 28, 2025
CN7:1h Alleviates Inflammation, Apoptosis and Extracellular Matrix Degradation in Osteoarthritis by Modulating the NF-κB and mTOR PathwaysChih-Chien Wang, Jeng-Wei Lu, Ya-Wun Wu, et al.
In Vivo (Athens, Greece)|October 30, 2024
Molecular Hydrogen Therapy in Sjögren's Syndrome With Pulmonary Arterial Hypertension and Right-sided Heart Failure: A Case Report of Improved Immune Markers Including Treg, B Cells and Plasma CellYun-Ting Lin, Jeng-Wei Lu, Chun-Hsien Wu, et al.
Food Science & Nutrition|March 3, 2025
Assessing Traditional Chinese Medicines for Anti-Dengue Using a National Health Insurance Research Database and BioassaysWan-Yu Su, Hsiang-Hui Lo, Yuan-Liang Wen, et al.
APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|July 13, 2023
Predicting the clinical efficacy of JAK inhibitor treatment for patients with rheumatoid arthritis based on Fas+ T cell subsetsShan-Wen Lui, Ting-Yu Hsieh, Jeng-Wei Lu, et al.
In Vivo (Athens, Greece)|October 30, 2025
A Case Report of Adjuvant Molecular Hydrogen Therapy in Refractory Rheumatoid Arthritis With Atlantoaxial SubluxationYou-Chi Ren, Jeng-Wei Lu, Yi-Jung Ho, et al.
Pageof 8